During a session at the this week’s World Stem Cell Summit in San Diego, an international research team described an “astonishing” experiment in which a mouse model of multiple sclerosis was able to virtually totally recover and move normally after being transplanted with human neural precursor cells (hNPC). The scientists were able to show almost full recovery in the mice up to six months later.
Recent Posts
- ‘Serial Killing’ Cell Therapy From Autolus Lands FDA Approval in Blood Cancer
- World-first stem-cell treatment restores vision in people
- Human stem cell-derived heart cells are safe in monkeys, could treat congenital heart disease
- Markers in iPSC quality control—a new approach to enhance standardization
- Nasal Spray Made From Stem Cells Could Treat Alzheimer’s Disease
- New Stem Cell Data From Space